With the discovery and development of new techniques in Genomics and Proteomics, it is now possible to do the gene and protein expression profiling of healthy versus diseased cells or tissues. It is predicted that in 20-30 years time, we may have a patient specific Molecular Medicine regimen after looking at the gene and protein expression status of that patient. Besides, when we understand the molecular mechanisms of disease development it is
possible to design a small molecule drug which specifically inhibits the disease or cancer causing proteins. The successful example of this approach is the drug Gleevec (STI571) which is a kinase inhibitor and is used in the treatment of Chronic Myeloid Leukemia.

A new field of regenerative medicine is emerging, where stem cells are being tested for potential therapy in all types of cancers, neurodegenerative disorders like Alzheimer’s and Parkinson’s etc. Induced Pluripotent Stem (iPS) cells have been generated from adult skin cells; these stem cells have the potential to become any type of cells from our body. That will be the future of medicine, in 10-15 years time, we may be able to produce any type of cells or
tissues just by using a few of your skin cells, convert them to stem cells and replace any bad cells from our body with the new healthy cells generated by stem cell technology. Stem cells will be used for drug target discovery and development and for testing the toxicity or side effects of drugs.

The objective of this program is to provide the training in the emerging field of Stem Cell Biology and prepare the human resources that will be needed to carry out research and development work, for experiments on stem cells to discover new drugs, for supporting the medical staff in generating patient specific stems cells and tissues for therapeutic purposes. This unique program will provide the students an opportunity to work in specialized labs in
government as well as private institutes and industries, for manufacturing the stem cells, in clinical research and trials after successfully completing the program. This program will expose the students to basic and applied aspects of various types of stem cells, application of stem cells, and the allied subjects like Molecular Biology and Immunology and bring them to a level of understanding, whereby they realize the importance of learning to a scientific application. To attain this goal, we will use a combined approach involving lectures, journal club discussions, oral presentations and exposure to research work in the laboratory.

Distinctive features

Theory and practical sessions by international faculty
Invited lectures and seminars by renowned scientists and industrialists
Special focus on molecular basis of human diseases and animal modeling of human diseases
One year full time research project to give a hands on training on molecular and biochemical techniques
Collaboration with industry as well as national and international institutes
Option to take electives in other compatible programs like Nanoscience and nanobiotechnology.

Focus Areas

• Embryonic stem cells
• Hematopoietic cancers
• Induced pluripotent stem cells (iPSCs)
• Biology and application of stem cells
• Hematopoietic stem cells

Eligibility

Bachelors or Masters Degree in any branch of Life Sciences, Medical Sciences,
Pharmaceutical Sciences, Chemical Sciences, Physical Sciences, Engineering and
Technology or equivalent (with minimum 55 percent marks or equivalent grades).

Program Faculty (including visiting faculty)

• Dr. Sheo Mohan Singh, MSc (UK), PhD (Germany), PDF (Germany, UK, USA)
• Prof Dr med Christian Buske, MD-PhD (Germany), PDF (USA)
• Dr. Michaela Feuring-Buske, MD-PhD (Germany), PDF (USA)
• Dr. TS Ganesan, MA (Oxford), MD, MNAMS, PhD (London), FRCP
• Dr. Rajani Kanth Vangala, PhD (Germany), PDF (Germany, Sweden, UK)
• Dr. Krishnakumar N. Menon, MSc-PhD (Australia), PDF (Japan, USA, Australia)
• Dr. Shree R. Singh, MS (USA), PhD (USA), PDF (USA)
• Dr. Javid Wani, PhD (Germany), PDF (USA)
• Dr. Arun Trivedi, PhD (Germany), PDF (Germany)
• Dr. Nitin Kulkarni, PhD (USA), PDF (USA)
• Dr. AA Peer Zada, PhD (Germany), PDF (Germany)
• Dr. Prashant Khadke, PhD (India), PDF (USA)
• Prof. Rabinder Henry, MSc (Germany)